ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic.
Blood
; 135(21): 1829-1832, 2020 05 21.
Article
in English
| MEDLINE | ID: covidwho-45899
ABSTRACT
The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Hematologic Neoplasms
/
Lymphoma
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Blood
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS